A well-trained team of armed security personnel may improve safety in healthcare facilities, experts say. However, this approach carries risks, and analysts emphasize the need for a multipronged approach to security.
Use of marijuana by expectant mothers in the United States rose 62 percent from 2002 through 2014, raising concerns among researchers even as legalization of pot has spread.
With research yielding sometimes discordant findings regarding long-term medical risks of football, physicians are looking for answers for parents concerned about youth participation.
A Kaiser Family Foundation poll in 2015 suggested nearly three-fourths of Americans consider drug prices unjustifiably high. Citing concerns about negative perceptions of drug pricing, the Health and Public Policy Committee of the American College of Physicians recently offered recommendations...
Research linking a poor diet to a variety of health conditions is overwhelming, spurring some hospitals to revamp their menus and eliminate fast food. As it turns out, those changes don’t have to break the bank.
Breast reconstructive surgery candidates often are not well-informed about the procedure or the risk of complications, recent research suggests.
Studies point to a frequent disconnect between the priorities of clinical investigators and patient and physician end users. Engaging patients and other stakeholders in research prioritization can enhance study relevance and may even shorten the time it takes to bring scientific discoveries from the laboratory to the bedside.
Job recruitment scams are common, and even if savvy physicians and other healthcare workers pull back the moment a phony recruiter requests bank account information, they can’t recoup time lost pursuing non-existent positions.
Time physicians spend entering data into EHRs during appointments may reduce patient satisfaction, a recent study in JAMA Internal Medicine suggests.
Pancreatic cancer is a paradox. It’s one of the deadliest cancers, yet it has one of the lowest research funding levels of all major cancer types. Scientists and advocates say those funding levels are due for a re-examination.
- 1 of 4
- next ›